Heroin abuse exaggerates age-related deposition of hyperphosphorylated tau and p62-positive inclusions

Neurobiology of Aging

Volumn 36, Issue 11, 2015, Pages 3100-3107

  Kovacs, Gabor G ^a,b   Horvath, Monika Cs ^c   Majtenyi, Katalin ^b   Lutz, Mirjam I ^a   Hurd, Yasmin L ^d   Keller, Eva ^b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b SEMMELWEIS UNIVERSITY   (Hungary)

^c UPPSALA UNIVERSITY   (Sweden)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; Heroin; Neuropathology; Opiate; p62; Tau; TDP 43; Synuclein

Indexed keywords

ALCOHOL; ALPHA SYNUCLEIN; AMPHETAMINE; AMYLOID BETA PROTEIN; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DIAMORPHINE; PROTEIN P62; TAR DNA BINDING PROTEIN; TAU PROTEIN; DNA BINDING PROTEIN; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; AGING; ALZHEIMER DISEASE; ARTICLE; BASAL AMYGDALA; BASAL GANGLION; BRAIN LEVEL; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; FRONTAL CORTEX; HEROIN DEPENDENCE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; MEDULLA OBLONGATA; MESENCEPHALON; NERVE DEGENERATION; NEUROPATHOLOGY; OCCIPITAL CORTEX; PONS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; TEMPORAL CORTEX; THALAMUS; BRAIN; METABOLISM; PATHOLOGY; PHOSPHORYLATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGING; ALPHA-SYNUCLEIN; ALZHEIMER DISEASE; BRAIN; DNA-BINDING PROTEINS; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; PHOSPHORYLATION; RNA-BINDING PROTEINS; TAU PROTEINS; YOUNG ADULT;

EID: 84947048054     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.07.018     Document Type: Article

References (31)

1. Albertson D.N., Schmidt C.J., Kapatos G., Bannon M.J. Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology 2006, 31:2304-2312.
2. Anthony I.C., Norrby K.E., Dingwall T., Carnie F.W., Millar T., Arango J.C., Robertson R., Bell J.E. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 2010, 133:3685-3698.
3. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
5. Braak H., Del Tredici K. The pathological process underlying Alzheimer's disease in individuals under thirty. Acta Neuropathol. 2011, 121:171-181.
6. Braak H., Thal D.R., Matschke J., Ghebremedhin E., Del Tredici K. Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons. Neurobiol. Aging 2013, 34:286-297.
7. Buttner A., Mall G., Penning R., Weis S. The neuropathology of heroin abuse. Forensic Sci. Int. 2000, 113:435-442.
8. Cadet J.L., Bisagno V., Milroy C.M. Neuropathology of substance use disorders. Acta Neuropathol. 2014, 127:91-107.
9. Crary J.F., Trojanowski J.Q., Schneider J.A., Abisambra J.F., Abner E.L., Alafuzoff I., Arnold S.E., Attems J., Beach T.G., Bigio E.H., Cairns N.J., Dickson D.W., Gearing M., Grinberg L.T., Hof P.R., Hyman B.T., Jellinger K., Jicha G.A., Kovacs G.G., Knopman D.S., Kofler J., Kukull W.A., Mackenzie I.R., Masliah E., McKee A., Montine T.J., Murray M.E., Neltner J.H., Santa-Maria I., Seeley W.W., Serrano-Pozo A., Shelanski M.L., Stein T., Takao M., Thal D.R., Toledo J.B., Troncoso J.C., Vonsattel J.P., White C.L., Wisniewski T., Woltjer R.L., Yamada M., Nelson P.T. Primary age-related tauopathy (PART): a common pathology associated with human aging. Acta Neuropathol. 2014, 128:755-766.
10. Deik A., Saunders-Pullman R., Luciano M.S. Substance abuse and movement disorders: complex interactions and comorbidities. Curr. Drug Abuse Rev. 2012, 5:243-253.
11. Dickson D.W., Crystal H.A., Mattiace L.A., Masur D.M., Blau A.D., Davies P., Yen S.H., Aronson M.K. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging 1992, 13:179-189.
12. Dickson D.W., Wertkin A., Kress Y., Ksiezak-Reding H., Yen S.H. Ubiquitin immunoreactive structures in normal human brains. Distribution and developmental aspects. Lab. Invest. 1990, 63:87-99.
13. Duyckaerts C., Delatour B., Potier M.C. Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 2009, 118:5-36.
14. Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006, 31:1036-1047.
15. Fang H., Zhang L.F., Meng F.T., Du X., Zhou J.N. Acute hypoxia promote the phosphorylation of tau via ERK pathway. Neurosci. Lett. 2010, 474:173-177.
16. Grinberg L.T., Rub U., Ferretti R.E., Nitrini R., Farfel J.M., Polichiso L., Gierga K., Jacob-Filho W., Heinsen H. The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?. Neuropathol. Appl. Neurobiol. 2009, 35:406-416. Brazilian Brain Bank Study, G.
17. Gruber S.A., Silveri M.M., Yurgelun-Todd D.A. Neuropsychological consequences of opiate use. Neuropsychol. Rev. 2007, 17:299-315.
18. Hauser K.F., Fitting S., Dever S.M., Podhaizer E.M., Knapp P.E. Opiate drug use and the pathophysiology of neuroAIDS. Curr. HIV Res. 2012, 10:435-452.
19. Horvath M.C., Kovacs G.G., Kovari V., Majtenyi K., Hurd Y.L., Keller E. Heroin abuse is characterized by discrete mesolimbic dopamine and opioid abnormalities and exaggerated nuclear receptor-related 1 transcriptional decline with age. J. Neurosci. 2007, 27:13371-13375.
20. Kanaan N.M., Kordower J.H., Collier T.J. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability. J. Comp. Neurol. 2007, 502:683-700.
21. Kovacs G.G. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol. Appl. Neurobiol. 2015, 41:3-23.
22. Kovacs G.G., Botond G., Budka H. Protein coding of neurodegenerative dementias: the neuropathological basis of biomarker diagnostics. Acta Neuropathol. 2010, 119:389-408.
23. Kovacs G.G., Breydo L., Green R., Kis V., Puska G., Lorincz P., Perju-Dumbrava L., Giera R., Pirker W., Lutz M., Lachmann I., Budka H., Uversky V.N., Molnar K., Laszlo L. Intracellular processing of disease-associated alpha-synuclein in the human brain suggests prion-like cell-to-cell spread. Neurobiol. Dis. 2014, 69:76-92.
24. Kovacs G.G., Milenkovic I., Wohrer A., Hoftberger R., Gelpi E., Haberler C., Honigschnabl S., Reiner-Concin A., Heinzl H., Jungwirth S., Krampla W., Fischer P., Budka H. Non-Alzheimer neurodegenerative pathologies and their combinations are more frequent than commonly believed in the elderly brain: a community-based autopsy series. Acta Neuropathol. 2013, 126:365-384.
25. Kuusisto E., Kauppinen T., Alafuzoff I. Use of p62/SQSTM1 antibodies for neuropathological diagnosis. Neuropathol. Appl. Neurobiol. 2008, 34:169-180.
26. Kuusisto E., Parkkinen L., Alafuzoff I. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. J. Neuropathol. Exp. Neurol. 2003, 62:1241-1253.
27. Nijholt D.A., De Kimpe L., Elfrink H.L., Hoozemans J.J., Scheper W. Removing protein aggregates: the role of proteolysis in neurodegeneration. Curr. Med. Chem. 2011, 18:2459-2476.
28. Ramage S.N., Anthony I.C., Carnie F.W., Busuttil A., Robertson R., Bell J.E. Hyperphosphorylated tau and amyloid precursor protein deposition is increased in the brains of young drug abusers. Neuropathol. Appl. Neurobiol. 2005, 31:439-448.
29. Sillivan S.E., Whittard J.D., Jacobs M.M., Ren Y., Mazloom A.R., Caputi F.F., Horvath M., Keller E., Ma'ayan A., Pan Y.X., Chiang L.W., Hurd Y.L. ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol. Psychol. 2013, 74:511-519.
30. Thal D.R., Rub U., Orantes M., Braak H. Phases of A beta-deposition in the human brain and its relevance for the development of AD. Neurology 2002, 58:1791-1800.
31. Xie C., Li S.J., Shao Y., Fu L., Goveas J., Ye E., Li W., Cohen A.D., Chen G., Zhang Z., Yang Z. Identification of hyperactive intrinsic amygdala network connectivity associated with impulsivity in abstinent heroin addicts. Behav. Brain Res. 2011, 216:639-646.